Neuronetics, Inc. Appoints Joseph H. Capper to Its Board of Directors and as Member of the Audit Committee, Effective January 1, 2023

Neuronetics, Inc. announced the appointment of Joseph H. Capper to its Board of Directors and as a member of the Audit Committee effective January 1, 2023. Mr. Capper brings nearly 30 years of med-tech and life sciences experience to the Company. Most recently, he served as President and Chief Executive Officer of BioTelemetry, Inc, the successor to CardioNet, Inc., and Home Diagnostics, Inc. Prior to Home Diagnostics, Joe was President and Chief Executive Officer of CCS Medical Inc., a private company.

Earlier, Joe spent nine years with Bayer Corporation, ultimately becoming National Sales Director of the Diabetic Products Division. Joe also has a distinguished service record, having served in the U.S. Navy as a combat aviator and later as a congressional liaison. Joe received his undergraduate degree in accounting from West Chester University and an MBA in International Finance from George Washington University.